Cited by 645Lung Cancer Research StudiesCancer-related Molecular PathwaysOccupational and environmental lung diseases

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

Open access

Meuwissen, Ralph, Linn, Sabine C, Linnoila, R.Ilona, Zevenhoven, John, Mooi, Wolter J, Berns, Anton·2003·Cancer Cell

Open this paper in CoChat — free account Open PDF

Abstract

Small cell lung cancer (SCLC) is a highly aggressive human tumor with a more than 95% mortality rate. Its ontogeny and molecular pathogenesis remains poorly understood. We established a mouse model for neuroendocrine (NE) lung tumors by conditional inactivation of Rb1 and Trp53 in mouse lung epithelial cells. Mice carrying conditional alleles for both Rb1 and Trp53 developed with high incidence aggressive lung tumors with striking morphologic and immunophenotypic similarities to SCLC. Most of these tumors, which we designate MSCLC (murine small cell lung carcinoma), diffusely spread through the lung and gave rise to extrapulmonary metastases. In our model, inactivation of both Rb1 and p53 was a prerequisite for the pathogenesis of SCLC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s1535-6108(03)00220-4

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
Bhattacharjee, A., Richards, W. G., Staunton, J. E., Li, C., Monti, S., Vasa, P. P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,558
Neuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1014 · Cited by 2,161
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint
Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,927
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Simplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. J. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,497
Self-citation
Diversity of gene expression in adenocarcinoma of the lung
Garber, M. E., Troyanskaya, O. G., Schlüns, K., Petersen, S., Thäsler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G., Perou, C. M., Whyte, R. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241500798 · Cited by 1,301
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer
Watkins, D. N., Berman, D. M., Burkholder, S. G., Wang, B., Beachy, P. A., & Baylin, S. B. (2003) · Nature · doi:10.1038/nature01493 · Cited by 1,082
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
Jonkers, J., Meuwissen, R. L. J., van der Gulden, H. M. L., Peterse, H. L., van der Valk, M., & Berns, A. J. M. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,044
Self-citation
Induction of medulloblastomas in p53 -null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
Marino, S., Vooijs, M., van der Gulden, H., Jonkers, J., & Berns, A. (2000) · Genes & Development · doi:10.1101/gad.14.8.994 · Cited by 920
Self-citation

Show all 49 references

Sorted by citations

Items 101–200 of 645

YAP drives fate conversion and chemoresistance of small cell lung cancer
Wu, Q., Guo, J., Liu, Y., Zheng, Q., Li, X., Wu, C., Dong, F., Chen, X., Ma, L., Xu, P., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg1850 · Cited by 127
Recent progress in mapping the emerging landscape of the small-cell lung cancer genome
Kim, K., Dunn, C. T., & Park, K.-S. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0349-5 · Cited by 123
Immune receptor inhibition through enforced phosphatase recruitment
Fernandes, R. A., Su, L., Nishiga, Y., Ren, J., Bhuiyan, A. M., Cheng, N., Kuo, C. J., Picton, L. K., Ohtsuki, S., Majzner, R. G., et al. (2020) · Nature · doi:10.1038/s41586-020-2851-2 · Cited by 123
KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming
Na, F., Pan, X., Chen, J., Chen, X., Wang, M., Chi, P., You, L., Zhang, L., Zhong, A., Zhao, L., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00361-6 · Cited by 124
Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
Kleczko, E. K., Kwak, J., Schenk, E. L., & Nemenoff, R. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00954 · Cited by 122
The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung
Gazdar, A. F., Savage, T. K., Johnson, J. E. B., Berns, A. J. M., Sage, J., Linnoila, R. I., MacPherson, D. P., McFadden, D. G., Farago, A. F., Jacks, T., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000459 · Cited by 121
Self-citation
Reactive Astrocytes in Brain Metastasis
Wasilewski, D., Priego, N., Torre, C. F., & Valiente, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00298 · Cited by 121
miR-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation
Cai, J., Wu, J., Zhang, H., Fang, L., Huang, Y., Yang, Y., Zhu, X., Li, R., & Li, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2651 · Cited by 123
Cancer Stem Cells and the Ontogeny of Lung Cancer
Peacock, C. D., & Watkins, D. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2702 · Cited by 119
Pulmonary neuroendocrine cells: physiology, tissue homeostasis and disease
Noguchi, M., Furukawa, K. T., & Morimoto, M. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.046920 · Cited by 115
Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas
Sutter, R., Shakhova, O., Bhagat, H., Behesti, H., Sutter, C., Penkar, S., Chadha, A. S., Bernays, R. L., Heppner, F. L., Schüller, U., et al. (2010) · Oncogene · doi:10.1038/onc.2009.472 · Cited by 113
Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights
Meador, C. B., & Hata, A. N. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107522 · Cited by 119
Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
Gao, J., Li, H.-R., Jin, C., Jiang, J., & Ding, J. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02075-1 · Cited by 113
Anticancer Activity of ZnO Nanoparticles against Human Small-Cell Lung Cancer in an Orthotopic Mouse Model
Tanino, R., Amano, Y., Tong, X., Sun, R., Tsubata, Y., Harada, M., Fujita, Y., & Isobe, T. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0018 · Cited by 111
EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway
Murai, F., Koinuma, D., Shinozaki‐Ushiku, A., Fukayama, M., Miyaozono, K., & Ehata, S. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.26 · Cited by 110
Lineage Plasticity in Cancer Progression and Treatment
Magnen, C. L., Shen, M. M., & Abate-Shen, C. T. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050224 · Cited by 105
New roles for the RB tumor suppressor protein
Liu, H., Dibling, B. C., Spike, B. T., Dirlam, A., & Macleod, K. F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.005 · Cited by 107
Retinoblastoma Tumor Suppressor: Where Cancer Meets the Cell Cycle
Knudsen, E. S., & Knudsen, K. E. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100713 · Cited by 106
The convergent roles of the nuclear factor I transcription factors in development and cancer
Chen, K., Lim, J. W. C., Richards, L. J., & Bunt, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.015 · Cited by 102
Sox2 Cooperates with Lkb1 Loss in a Mouse Model of Squamous Cell Lung Cancer
Mukhopadhyay, A., Berrett, K. C., Kc, U., Clair, P. M., Pop, S., Carr, S. R., Witt, B. L., & Oliver, T. G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.036 · Cited by 102
Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis
Qu, F., Brough, S. C., Michno, W., Madubata, C. J., Hartmann, G. G., Puno, A., Drainas, A. P., Bhattacharya, D., Tomasich, E., Lee, M. C., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01241-6 · Cited by 103
A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype
Syder, A. J., Karam, S. M., Mills, J. C., Ippolito, J. E., Ansari, H. R., Farook, V. S., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307983101 · Cited by 100
Early Events in the Molecular Pathogenesis of Lung Cancer
Kadara, H. N., Scheet, P. A., Wistuba, I. I., & Spira, A. E. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0400 · Cited by 102
Using Genetically Engineered Mouse Models of Cancer to Aid Drug Development: An Industry Perspective
Singh, M., & Johnson, L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0437 · Cited by 98
Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin β1
Zhao, G., Gong, L., Su, D., Jin, Y., Guo, C., Yue, M., Yao, S., Qin, Z., Ye, Y., Tang, Y., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122779 · Cited by 98
Cellular and molecular biology of small cell lung cancer: an overview.
Karachaliou, N., Pilotto, S., Lazzari, C., Bria, E., de Marinis, F., & Rosell, R. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2016.01.02 · Cited by 96
Genetic requirement forMycland efficacy of RNA Pol I inhibition in mouse models of small cell lung cancerPreprint
Kim, D. W., Wu, N., Kim, Y., Cheng, P. F., Basom, R., Kim, D., Dunn, C. T., Lee, A. Y., Kim, K., Lee, C. S., et al. (2016) · Genes & Development · doi:10.1101/gad.279307.116 · Cited by 96
CDK4 and MDM2 Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-type INK4a/ARF Locus
Hernández, L., Beà, S., Pinyol, M., Ott, G., Katzenberger, T., Rosenwald, A., Bosch, F., López‐Guillermo, A., Delabie, J., Colomer, D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1526 · Cited by 95
MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivityPreprint
Grunblatt, E., Wu, N., Zhang, H., Liu, X., Norton, J. P., Ohol, Y. M., Leger, P. R., Hiatt, J. B., Eastwood, E., Thomas, R., et al. (2020) · Genes & Development · doi:10.1101/gad.340133.120 · Cited by 93
Antithetical NFATc1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity
Singh, S. K., Chen, N., Heßmann, E., Siveke, J. T., Lahmann, M., Singh, G., Völker, N., Vogt, S., Esposito, I., Schmidt, A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201489574 · Cited by 95
Family matters: How MYC family oncogenes impact small cell lung cancer
Brägelmann, J., Böhm, S., Guthrie, M. R., Mollaoglu, G., Oliver, T. G., & Sos, M. L. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1339849 · Cited by 95
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
Schulze, A. B., Evers, G., Kerkhoff, A., Möhr, M., Schliemann, C., Berdel, W. E., & Schmidt, L. H. (2019) · Cancers · doi:10.3390/cancers11050690 · Cited by 91
Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment
Zhu, Y., Cui, Y., Zheng, X., Zhao, Y. M., & Sun, G. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166557 · Cited by 94
Current knowledge of small cell lung cancer transformation from non-small cell lung cancer
Giaccone, G., & He, Y. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.05.006 · Cited by 95
Rb family proteins differentially regulate distinct cell lineages during epithelial development
Wikenheiser‐Brokamp, K. A. (2004) · Development · doi:10.1242/dev.01232 · Cited by 90
MiR-215 modulates gastric cancer cell proliferation by targeting RB1
Deng, Y., Zhenxia, H., Xu, Y., Jin, J. F., Zhuo, W., Zhang, C., Zhang, X., Shen, M., Yan, X., Wang, L., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.033 · Cited by 91
Circulating tumor cells and CDX models as a tool for preclinical drug development
Lallo, A., Schenk, M. W., Frese, K. K., Blackhall, F. H., & Dive, C. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.08.01 · Cited by 94
Rapid target gene validation in complex cancer mouse models using re‐derived embryonic stem cells
Huijbers, I. J., Ali, R. B., Pritchard, C. E. J., Cozijnsen, M., Kwon, M., Proost, N., Song, J., de Vries, H., Badhai, J., Sutherland, K., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303297 · Cited by 89
Self-citation
Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis
Zhu, M., Huang, Y., Bender, M. E., Girard, L., Kollipara, R. K., Eglenen-Polat, B., Naito, Y., Savage, T. K., Huffman, K. E., Koyama, S., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2808 · Cited by 84
Functional synapses between neurons and small cell lung cancer
Sakthivelu, V., Schmitt, A., Odenthal, F., Ndoci, K., Touet, M., Shaib, A., Chihab, A. W., Wani, G. A., Nieper, P., Hartmann, G. G., et al. (2025) · Nature · doi:10.1038/s41586-025-09434-9 · Cited by 97
Proteomic analysis of pRb loss highlights a signature of decreased mitochondrial oxidative phosphorylationPreprint
Nicolay, B., Danielian, P. S., Kottakis, F., Lapek, J. D., Sanidas, I., Miles, W. O., Dehnad, M., Tschöp, K., Gierut, J. J., Manning, A. L., et al. (2015) · Genes & Development · doi:10.1101/gad.264127.115 · Cited by 84
Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer
Shaurova, T., Zhang, L., Goodrich, D. W., & Hershberger, P. A. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00281 · Cited by 82
Harnessing Natural Killer Immunity in Metastatic SCLC
Best, S. A., Hess, J. B., Souza-Fonseca-Guimarães, F., Cursons, J., Kersbergen, A. J., Dong, X., Rautela, J., Hyslop, S. R., Ritchie, M. E., Davis, M. J., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.05.008 · Cited by 84
ROLE OF INFLAMMATION IN MOUSE LUNG TUMORIGENESIS: A Review
Malkinson, A. M. (2004) · Experimental Lung Research · doi:10.1080/01902140490495020 · Cited by 84
In vivo animal models for studying brain metastasis: value and limitations
Daphu, I., Sundstrøm, T., Horn, S. A., Huszthy, P. C., Niclou, S. P., Sakariassen, P. Ø., Immervoll, H., Miletić, H., Bjerkvig, R., & Thorsen, F. A. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9566-9 · Cited by 84
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy
Kazarian, M., & Laird‐Offringa, I. A. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-33 · Cited by 85
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
Jahchan, N. S., Lim, J. S., Bola, B. M., Morris, K. L., Seitz, G., Tran, K. Q. T., Xu, L., Trapani, F., Morrow, C. J., Cristea, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.021 · Cited by 83
Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET
Jia, Y., Vong, J. S. L., Asafova, A., Garvalov, B. K., Caputo, L., Cordero, J., Singh, A., Boettger, T., Günther, S., Fink, L., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181394 · Cited by 84
Skp2 Deletion Unmasks a p27 Safeguard that Blocks Tumorigenesis in the Absence of pRb and p53 Tumor Suppressors
Zhao, H., Bauzon, F., Fu, H., Lu, Z., Cui, J., Nakayama, K., Nakayama, K. I., Locker, J. D., & Zhu, L. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.021 · Cited by 80
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer
Dammert, M. A., Brägelmann, J., Olsen, R. R., Böhm, S., Monhasery, N., Whitney, C. P., Chalishazar, M. D., Tumbrink, H. L., Guthrie, M. R., Klein, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11371-x · Cited by 82
Small cell lung cancer: Subtypes and therapeutic implications
Wang, W., Shulman, A., Amann, J. M., Carbone, D. P., & Tsichlis, P. N. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.001 · Cited by 83
MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer
Augert, A., Mathsyaraja, H., Ibrahim, A. H., Freie, B. W., Geuenich, M., Cheng, P.-F., Alibeckoff, S. P., Wu, N., Hiatt, J. B., Basom, R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.016 · Cited by 80
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
Wu, N., Jia, D., Ibrahim, A. H., Bachurski, C. J., Gronostajski, R. M., & MacPherson, D. P. (2016) · Oncotarget · doi:10.18632/oncotarget.11583 · Cited by 77
CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer
Ng, S. R., Rideout, W. M., Akama‐Garren, E. H., Bhutkar, A. J., Mercer, K. L., Schenkel, J. M., Bronson, R. T., & Jacks, T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821893117 · Cited by 78
Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway
Demelash, A., Rudrabhatla, P., Pant, H. C., Wang, X., Amin, N. D., McWhite, C. D., Naizhen, X., & Linnoila, R. I. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-12-1010 · Cited by 76
Self-citation
What have animal models taught us about the p53 pathway?
Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 78
Dissecting metastasis using preclinical models and methods
Hebert, J. D., Neal, J. W., & Winslow, M. M. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00568-4 · Cited by 78
Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasisPreprint
Kwon, M.-C., Proost, N., Song, J., Sutherland, K. D., Zevenhoven, J., & Berns, A. J. M. (2015) · Genes & Development · doi:10.1101/gad.262998.115 · Cited by 74
Self-citation
Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer
Patel, A. S., Yoo, S., Kong, R., Sato, T., Sinha, A., Karam, S., Bao, L., Fridrikh, M., Emoto, K., Nudelman, G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abc2578 · Cited by 73
Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors
Dorantes-Heredia, R., Ruiz-Morales, J. M., & Cano-García, F. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.07.10 · Cited by 73
Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer
Wikman, H., & Kettunen, E. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.4.515 · Cited by 74
Anti‐VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models
Singh, M., Couto, S. S., Forrest, W. F., Lima, A., Cheng, J. H., Molina, R., Long, J. E., Hamilton, P., McNutt, A., Kasman, I. M., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4053 · Cited by 72
Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies
Kawasaki, K., Rekhtman, N., Quintanal-Villalonga, À., & Rudin, C. M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00696-0 · Cited by 71
Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737
Hauck, P. M., Chao, B. H., Litz, J., & Krystal, G. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1118 · Cited by 72
The Related Retinoblastoma (pRb) and p130 Proteins Cooperate to Regulate Homeostasis in the Intestinal Epithelium
Haigis, K. M., Sage, J., Glickman, J. N., Shafer, S. A., & Jacks, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509053200 · Cited by 72
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity
Simpson, K., Rothwell, D. G., Blackhall, F. H., & Dive, C. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00803-0 · Cited by 70
Cell of origin of lung cancer
Onaitis, M. W., & Hanna, J. M. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.109033 · Cited by 70
Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease
Angeloni, D. (2007) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elm007 · Cited by 71
Lineage factors and differentiation states in lung cancer progression
Cheung, W. K. C., & Nguyen, D. X. (2015) · Oncogene · doi:10.1038/onc.2015.85 · Cited by 71
Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer
Carr, A. C., Khaled, A. S., Bassiouni, R., Flores, O., Nierenberg, D., Bhatti, H. A., Vishnubhotla, P., Perez, J. M., Santra, S., & Khaled, A. R. (2017) · Oncotarget · doi:10.18632/oncotarget.22681 · Cited by 67
Notch Signaling Controls Transdifferentiation of Pulmonary Neuroendocrine Cells in Response to Lung Injury
Yao, E., Lin, C., Wu, Q., Zhang, K., Song, H., & Chuang, P. (2017) · Stem Cells · doi:10.1002/stem.2744 · Cited by 68
Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse models
Shue, Y. T., Lim, J. S., & Sage, J. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.01.15 · Cited by 68
Distinct and Overlapping Sarcoma Subtypes Initiated from Muscle Stem and Progenitor Cells
Blum, J. M., Añó, L., Li, Z., Mater, D. V., Bennett, B. J., Sachdeva, M., Lagutina, I. V., Zhang, M., Mito, J. K., Dodd, L. G., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.020 · Cited by 68
NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer
Rao, X., Zhou, X., Wang, G., Jie, X., Xing, B., Xu, Y., Chen, Y., Li, J., Zhu, K., Wu, Z., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05336-0 · Cited by 69
Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of Retinoblastoma and Trp53 Tumor Suppressors
Martínez-Cruz, A. B., Santos, M., Lara, M. F., Segrelles, C., Ruiz, S., Moral, M., Lorz, C., García-Escudero, R., & Paramio, J. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3049 · Cited by 65
From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers
Gazdar, A. F., Hirsch, F. R., & Minna, J. D. (2015) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.10.009 · Cited by 64
Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
Blackhall, F. H., Frese, K. K., Simpson, K., Kilgour, E., Brady, G., & Dive, C. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30455-8 · Cited by 66
Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
Doerr, F., George, J., Schmitt, A., Beleggia, F., Rehkämper, T., Hermann, S., Walter, V., Weber, J.-P. D., Thomas, R. K., Wittersheim, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15840-5 · Cited by 63
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
Cargill, K. R., Stewart, C. A., Park, E. M., Ramkumar, K., Gay, C. M., Cardnell, R. J., Wang, Q., Diao, L., Shen, L., Fan, Y.-H., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00270-9 · Cited by 62
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types
Chen, W. S., Alshalalfa, M., Zhao, S. G., Liu, Y., Mahal, B. A. V., Quigley, D. A., Wei, T., Davicioni, E., Rebbeck, T. R., Kantoff, P. W., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0404 · Cited by 62
Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer
Böttger, F., Semenova, E. A., Song, J., Ferone, G., van der Vliet, J., Cozijnsen, M., Bhaskaran, R., Bombardelli, L., Piersma, S. R., Pham, T. V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.057 · Cited by 60
Self-citation
Advances in Small-Cell Lung Cancer (SCLC) Translational ResearchPreprint
Drapkin, B. J., & Rudin, C. M. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038240 · Cited by 63
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival
Kellish, P. C., Shabashvili, D. E., Rahman, M. M., Nawab, A., Guijarro, M. V., Zhang, M., Cao, C., Moussatché, N., Boyle, T. A., Antonia, S. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121323 · Cited by 63
The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer
Szczepny, A., Rogers, S., Jayasekara, W. S. N., Park, K., McCloy, R. A., Cochrane, C. R., Ganju, V., Cooper, W. A., Sage, J., Peacock, C. D., et al. (2017) · Oncogene · doi:10.1038/onc.2017.173 · Cited by 59
Lung cancer stem cells: Molecular features and therapeutic targets
Singh, S., & Chellappan, S. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.08.003 · Cited by 57
Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases
Greer, S., Nadauld, L. D., Lau, B. T., Chen, J., Wood-Bouwens, C. M., Ford, J. M., Kuo, C. J., & Ji, H. P. (2017) · Genome Medicine · doi:10.1186/s13073-017-0447-8 · Cited by 58
From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies
Ottaiano, A., Ianniello, M., Santorsola, M., Ruggiero, R., Sirica, R., Sabbatino, F., Perri, F., Cascella, M., Marzo, M. D., Berretta, M., et al. (2023) · Biology · doi:10.3390/biology12091183 · Cited by 60
p53 suppresses carcinoma progression by inhibiting mTOR pathway activation
Akeno, N., Miller, A. L., Ma, X., & Wikenheiser‐Brokamp, K. A. (2014) · Oncogene · doi:10.1038/onc.2013.589 · Cited by 57
A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic niche
Oliver, C. R., Altemus, M., Westerhof, T. M., Cheriyan, H., Cheng, X., Dziubinski, M., Wu, Z., Yates, J. A., Morikawa, A., Heth, J., et al. (2019) · Lab on a Chip · doi:10.1039/c8lc01387j · Cited by 56
REPLATINUM Phase III Randomized Study: RRx-001 + Platinum Doublet Versus Platinum Doublet in Third-Line Small Cell Lung Cancer
Oronsky, B. T., Reid, T. R., Larson, C., Caroen, S. Z., Quinn, M. G., Burbano, E., Varner, G., Thilagar, B., Brown, B., Coyle, A., et al. (2019) · Future Oncology · doi:10.2217/fon-2019-0317 · Cited by 56
ASCL1, NKX2-1, and PROX1 co-regulate subtype-specific genes in small-cell lung cancer
Pozo, K., Kollipara, R. K., Kelenis, D. P., Rodarte, K. E., Ullrich, M. S., Zhang, X., Minna, J. D., & Johnson, J. E. B. (2021) · iScience · doi:10.1016/j.isci.2021.102953 · Cited by 58
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
Liang, S., Hsu, C.-C., Song, H., Huang, Y.-C., Kuo, C.-W., Yao, X., Li, C., Yang, H.-C., Hung, Y.-L., Chao, S.-Y., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01895-2 · Cited by 54
The adaptive immune response to sporadic cancer
Willimsky, G., & Blankenstein, T. J. F. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00578.x · Cited by 61
Modeling metastasis in mice: a closer look
Giacobbe, A., & Abate-Shen, C. T. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.06.010 · Cited by 51
Genetically-engineered mouse models of small cell lung cancer: the next generation
Oser, M. G., MacPherson, D. P., Oliver, T. G., Sage, J., & Park, K.-S. (2024) · Oncogene · doi:10.1038/s41388-023-02929-7 · Cited by 54
Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer
Solta, A., Ernhofer, B., Boettiger, K., Megyesfalvi, Z., Heeke, S., Hoda, M. A., Lang, C., Aigner, C., Hirsch, F. R., Schelch, K., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01953-9 · Cited by 56
Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs
Huang, X., Wang, J., Lin, W., Zhang, N., Du, J., Long, Z., Yang, Y. Q., Zheng, B., Zhong, F., Wu, Q., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153154 · Cited by 54
FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice
Ferone, G., Song, J., Krijgsman, O., van der Vliet, J., Cozijnsen, M., Semenova, E. A., Adams, D. J., Peeper, D. S., & Berns, A. J. M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.052 · Cited by 53
Self-citation
Signal control through Raf: in sickness and in health
Osborne, J. K., Zaganjor, E., & Cobb, M. H. (2011) · Cell Research · doi:10.1038/cr.2011.193 · Cited by 52
Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives
Krpina, K., Vranić, S., Tomić, K., Samaržija, M., & Batičić, L. (2023) · Biomedicines · doi:10.3390/biomedicines11071982 · Cited by 51

Authors: Meuwissen, R., Linn, S. C., Linnoila, R. I., Zevenhoven, J., Mooi, W. J., & Berns, A.
Affiliations: The Netherlands Cancer Institute (NL)
National Cancer Institute (US)
Corresponding author: Berns, Anton
ORCID: Meuwissen, Ralph
Linn, Sabine C
Berns, Anton
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2003-09
Volume: 4
Issue: 3
Pages: 181-189
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/s1535-6108(03)00220-4
OpenAlex: W1978286483
Cited by: 643
References: 49
Citations by year: 2026: 22 · 2025: 41 · 2024: 30 · 2023: 43 · 2022: 43 · 2021: 40 · 2020: 33 · 2019: 43 · 2018: 34 · 2017: 34 · 2016: 27 · 2015: 31 · 2014: 27 · 2013: 24 · 2012: 16
FWCI: 8.70
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 3607 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Funders: KWF Kankerbestrijding
Topics: Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords: small cell lung cancer, lung neuroendocrine tumors, Trp53, RB1, conditional knockout mice, carcinogenesis, p53, retinoblastoma protein, lung epithelial cells, metastasis, mouse model
MeSH terms: Animals, DNA-Binding Proteins, Lung Neoplasms, Mice, Transgenic, Transcription Factors, Gene Expression Regulation, Neoplastic, Genes, p53, Tumor Suppressor Protein p53, Retinoblastoma Protein, Carcinoma, Small Cell, Mice, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks